DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development

The Drug Information Association (DIA) will present FDA, EMEA, Health Canada, emerging region, NGO, and industry perspectives on Global Vaccine Development at the Global Vaccine Development for World Health Symposium from November 3-4 in Bethesda, MD.

Horsham, PA (Vocus/PRWEB ) September 29, 2009 -- The Drug Information Association (DIA) will present FDA, EMEA, Health Canada, emerging region, NGO, and industry perspectives on Global Vaccine Development at the Global Vaccine Development for World Health Symposium from November 3-4 in Bethesda, MD. This two-day symposium will address the regulatory pathways for the development of global vaccines to treat infectious diseases such as tuberculosis, malaria and H1N1.

In September 2008 the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) published an important FDA Guidance Document that will expand the FDA's role in facilitating the development of new vaccines for global bacterial, viral, and parasitic diseases affecting millions of people in developing countries worldwide

This symposium will explore this new guidance in depth and discuss the necessary paths to develop vaccines for global diseases.

Representatives and regulatory experts from the US Food and Drug Administration (FDA), World Health Organization (WHO), Bill & Melinda Gates Foundation, International Vaccine Initiative (IVI), Developing Countries Regulatory Network (DCRN), and BIO Ventures for Global Health (BVGH) will discuss strategies for the development and regulation of preventative vaccines for global diseases. Special emphasis will be given to the WHO prequalification process and FDAAA voucher program relative to global vaccine development for world health. Session topics will include:

Regulatory Approaches and Pathways for Global Vaccine Development: FDA, EMEA, Emerging Regions and Industry Perspectives Prequalification of Global Vaccines Special Presentation on Ethical Considerations in Global Vaccine Development Novel Approaches to Global Vaccine Development Global Vaccine Development: Path Forward and Open Dialogue Speakers will include: Norman Baylor, PhD, Director, Office of Vaccines Research & Review (OVRR), CBER, FDA David Wood, PhD, Coordinator of the Quality, Safety & Standards Team of the Department of Immunization, Vaccines & Biologicals, WHO Vincent Ahonkhai, MD: Senior Regulatory Officer, Global Health Delivery, Bill and Melinda Gates Foundation Christine Grady, MSN, PhD, Head Section on Human Subjects Research, Department of Bioethics, National Institutes of Health Clinical Center

Jesse Goodman, MD, MPH, Acting Chief Scientist & Deputy Commissioner for Scientific & Medical Programs for FDA, will deliver the keynote address.

"In September 2008 the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) published an important FDA Guidance Document that will expand the FDA's role in facilitating the development of new vaccines for global bacterial, viral, and parasitic diseases affecting millions of people in developing countries worldwide," explains Program Co-chair Michael Brennan, PhD, Senior Advisor for Global Affairs, Aeras Global TB Vaccine Foundation. "This symposium will explore this new guidance in depth and discuss the necessary paths to develop vaccines for global diseases."

Click here to register.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact: Joe Krasowski
DIA
+1-215-293-5812

See Also:

• Massachusetts Lawyer Launches New Blog Regarding DUI, License Suspensions, Hardship Licenses, and the Ignition Interlock Device
• New Orleans-Based Law Firm Ranks In Top 10 For Insurance Litigation
• Police Officers from Carolinas Treated to Panthers-Cowboys Monday Night Game at New Stadium by Dallas-Based LeadsOnline
• New York Personal Injury Lawyers Comment on Taxi Slamming into a Horse-Drawn Carriage, Injuring Two
• Novus Law Announces Winners of Its Legal Document Challenge and Launches Newly Improved Website

[Via Legal / Law]

• buy generic accutane - order isotretinoin online
• cheap propecia - order generic propecia online
• viagra kaufen forum
• buy valium without prescription - buy valium
• cialis kaufen ohne rezept - viagra kaufen